Brian McGreen

Philadelphia University

Papers

1

Total Citations

2

H-Index

1

About

Brian McGreen is a urologic oncologist whose research focuses on the clinical management of bladder cancer, particularly in patients undergoing radical cystectomy for urothelial carcinoma. His most cited work, published in the *Journal of Urology* (2017), investigates the clinical destiny of indeterminate pulmonary nodules detected in this high-risk population. By analyzing outcomes in patients with these nodules, McGreen and his colleagues provided critical insights into whether such findings represent metastatic disease or benign processes—a distinction that directly influences treatment decisions and prognosis. This study, co-authored with leading experts like David Cahn and Elizabeth Plimack, has informed risk stratification and surveillance protocols, helping to avoid unnecessary interventions while ensuring timely detection of recurrence. Though his citation count is modest, McGreen’s contribution addresses a practical, high-stakes dilemma in urologic oncology: how to interpret ambiguous imaging findings in patients already facing aggressive disease. His work underscores the importance of evidence-based decision-making in complex cancer care, offering guidance to clinicians navigating the uncertainty of pulmonary nodules post-cystectomy. For researchers and trainees, McGreen’s study exemplifies how focused clinical questions can yield actionable insights that improve patient outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
MP58-12 CLINICAL DESTINY OF INDETERMINATE PULMONARY NODULES IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR UROTHELIAL CARCINOMA OF THE BLADDER
2 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Philadelphia University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago